Clinical Trials Browser

Phase 2/3 × Biliary Tract Neoplasms × Paclitaxel × Clear all

NCT05506943 2025-04-20

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Phase 2/3 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma